Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03697187 · ClinicalTrials.gov registry record
Patient Registry to Evaluate the Real-world Safety of Ruconest®
A clinical trial, sponsored by Pharming Technologies B.V..
- Completed
- Registry status
- 152
- Enrollment target
NCT03697187 is a clinical trial that has completed, run by Pharming Technologies B.V.. The registered enrollment target is 152 participants.
The verdict
NCT03697187 has completed, sponsored by Pharming Technologies B.V..
- COMPLETED
- Registry status
- 152 participants
- Enrollment target
Study Summary
This is a prospective, real-world, observational patient registry for patients with HAE who are receiving treatment with Ruconest for HAE.
Interventions
- DRUG rhC1INH
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2018-06-30 |
| Est. Completion | 2021-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03697187
The ClinicalTrials.gov registry entry for NCT03697187 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pharming Technologies B.V., which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which rhC1INH is the first listed.
NCT03697187 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03697187 about?
NCT03697187 is a clinical study titled "Patient Registry to Evaluate the Real-world Safety of Ruconest®". This is a prospective, real-world, observational patient registry for patients with HAE who are receiving treatment with Ruconest for HAE.
What is the current status of trial NCT03697187?
This trial is currently completed. The enrollment target is 152 participants. The study started on 2018-06-30. Estimated completion is 2021-07-31.
What interventions are being tested in trial NCT03697187?
The interventions under investigation include: rhC1INH (DRUG).
Who is sponsoring clinical trial NCT03697187?
This trial is sponsored by Pharming Technologies B.V., which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.